Guowei Wang

638 total citations
41 papers, 455 citations indexed

About

Guowei Wang is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Guowei Wang has authored 41 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Infectious Diseases. Recurrent topics in Guowei Wang's work include Drug Transport and Resistance Mechanisms (5 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). Guowei Wang is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Microbial Natural Products and Biosynthesis (3 papers). Guowei Wang collaborates with scholars based in China, Czechia and New Zealand. Guowei Wang's co-authors include Lina Han, Shuli Guo, Zhihua Liao, Bingchen Wang, Min Chen, Zhen Zhang, Huige Zhou, Nasha Qiu, Ru Bai and Wentao Yang and has published in prestigious journals such as Advanced Materials, Journal of Environmental Management and Journal of Ethnopharmacology.

In The Last Decade

Guowei Wang

38 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guowei Wang China 12 115 78 59 58 53 41 455
Di Jin China 16 266 2.3× 89 1.1× 121 2.1× 72 1.2× 38 0.7× 43 756
Chong Geng China 13 131 1.1× 95 1.2× 61 1.0× 95 1.6× 22 0.4× 33 492
Wei Jiao China 13 105 0.9× 59 0.8× 49 0.8× 19 0.3× 15 0.3× 43 575
Yuan‐Hao Lee Taiwan 12 144 1.3× 43 0.6× 52 0.9× 33 0.6× 27 0.5× 33 333
Mao Xie China 16 169 1.5× 139 1.8× 50 0.8× 40 0.7× 25 0.5× 44 634
Yeon Kim South Korea 16 302 2.6× 95 1.2× 54 0.9× 34 0.6× 68 1.3× 59 806
Yanxiang Zhang China 17 221 1.9× 197 2.5× 135 2.3× 55 0.9× 127 2.4× 54 834
M. Anburajan India 12 45 0.4× 120 1.5× 34 0.6× 178 3.1× 29 0.5× 55 578
Sha Li China 17 212 1.8× 75 1.0× 58 1.0× 144 2.5× 62 1.2× 54 882

Countries citing papers authored by Guowei Wang

Since Specialization
Citations

This map shows the geographic impact of Guowei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guowei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guowei Wang more than expected).

Fields of papers citing papers by Guowei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guowei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guowei Wang. The network helps show where Guowei Wang may publish in the future.

Co-authorship network of co-authors of Guowei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Guowei Wang. A scholar is included among the top collaborators of Guowei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guowei Wang. Guowei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Guowei, et al.. (2025). Decoupled Prototype Learning for Reliable Test-Time Adaptation. IEEE Transactions on Multimedia. 27. 3585–3597. 2 indexed citations
2.
3.
Mao, Jingxin, Guowei Wang, Lihong Tan, et al.. (2023). Combined Network Pharmacology and Molecular Docking to Verify the Treatment of Type 2 Diabetes with Pueraria Lobata Radix and Salviae Miltiorrhizae Radix. Computational and Mathematical Methods in Medicine. 2023(1). 9150324–9150324. 8 indexed citations
4.
Chen, Xinpeng, et al.. (2023). Improved GoogleNet Model for Tired Driving Detection. 1–7.
5.
Li, Fan, Yun Feng, Guowei Wang, et al.. (2023). Tracing the spatiotemporal phylodynamics of Japanese encephalitis virus genotype I throughout Asia and the western Pacific. PLoS neglected tropical diseases. 17(4). e0011192–e0011192. 9 indexed citations
6.
Chen, Lin, et al.. (2023). The discovery of a new potent FXR agonist based on natural product screening. Bioorganic Chemistry. 143. 106979–106979. 5 indexed citations
7.
Liu, Die, Mingyun Chen, Wei Zong, et al.. (2022). Effects of Sedi Herba (Sedum sarmentosum) on attenuating cholestasis by the activation of the farnesoid x receptor (FXR)-mediated signaling. Biomedicine & Pharmacotherapy. 155. 113803–113803. 8 indexed citations
8.
Zhang, Weijia, Guowei Wang, Shihong Fu, et al.. (2022). A Bibliometric Analysis of Global Research on Japanese Encephalitis From 1934 to 2020. Frontiers in Cellular and Infection Microbiology. 12. 833701–833701. 11 indexed citations
9.
Wang, Guowei, et al.. (2022). Asymptomatic COVID-19 CT image denoising method based on wavelet transform combined with improved PSO. Biomedical Signal Processing and Control. 76. 103707–103707. 12 indexed citations
10.
Wang, Guowei, et al.. (2022). COVID-19 ground-glass opacity segmentation based on fuzzy c-means clustering and improved random walk algorithm. Biomedical Signal Processing and Control. 79. 104159–104159. 3 indexed citations
11.
Guo, Shuli, et al.. (2022). COVID-19 CT image denoising algorithm based on adaptive threshold and optimized weighted median filter. Biomedical Signal Processing and Control. 75. 103552–103552. 36 indexed citations
12.
13.
Lu, Huiqiang, Qinghong Zeng, Fancheng Meng, et al.. (2021). Ptehoosines A and B: Two new sesamin-type sesquilignans with antiangiogenic activity from Pterocephalus hookeri (C.B. Clarke) Höeck. Fitoterapia. 151. 104886–104886. 7 indexed citations
14.
Wang, Guowei & Bao-Ming Li. (2020). Efficacy of surgery for the treatment of astrocytoma. Medicine. 99(23). e20485–e20485. 3 indexed citations
15.
Li, Li, et al.. (2020). Peripheral Blood Leukocytes and Platelets Serve as Prognostic Factors in Breast Cancer. Cancer Biotherapy and Radiopharmaceuticals. 36(2). 167–173. 11 indexed citations
16.
17.
18.
Wu, Bihan, Guowei Wang, Xin Lei, et al.. (2020). Network pharmacology-based therapeutic mechanism of Kuanxiong aerosol for angina pectoris. Journal of Ethnopharmacology. 261. 113079–113079. 9 indexed citations
19.
Zhu, Jingjing, Weihong Hou, Yong Xu, et al.. (2019). Antipsychotic drugs and sudden cardiac death: A literature review of the challenges in the prediction, management, and future steps. Psychiatry Research. 281. 112598–112598. 39 indexed citations
20.
Tao, Xumei, et al.. (2016). A novel two-level dielectric barrier discharge reactor for methyl orange degradation. Journal of Environmental Management. 184(Pt 3). 480–486. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Di Jin Breakdown of academic impact, for papers by Chong Geng Breakdown of academic impact, for papers by Wei Jiao Breakdown of academic impact, for papers by Yuan‐Hao Lee Breakdown of academic impact, for papers by Mao Xie Breakdown of academic impact, for papers by Yeon Kim Breakdown of academic impact, for papers by Yanxiang Zhang Breakdown of academic impact, for papers by M. Anburajan Breakdown of academic impact, for papers by Sha Li
Rankless by CCL
2026